- Home
- HCC vs OGN Comparison
HCC vs OGN Comparison
Compare HCC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- OGN
- Stock Information
- Founded
- HCC 2015
- OGN 1923
- Country
- HCC United States
- OGN United States
- Employees
- HCC N/A
- OGN N/A
- Industry
- HCC Coal Mining
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- HCC Energy
- OGN Health Care
- Exchange
- HCC Nasdaq
- OGN Nasdaq
- Market Cap
- HCC 2.9B
- OGN 2.5B
- IPO Year
- HCC 2017
- OGN N/A
- Fundamental
- Price
- HCC $60.75
- OGN $9.21
- Analyst Decision
- HCC Buy
- OGN Hold
- Analyst Count
- HCC 6
- OGN 4
- Target Price
- HCC $66.80
- OGN $18.00
- AVG Volume (30 Days)
- HCC 1.2M
- OGN 4.4M
- Earning Date
- HCC 08-06-2025
- OGN 08-05-2025
- Dividend Yield
- HCC 0.53%
- OGN 0.87%
- EPS Growth
- HCC N/A
- OGN N/A
- EPS
- HCC 0.77
- OGN 2.69
- Revenue
- HCC $1,221,350,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- HCC N/A
- OGN N/A
- Revenue Next Year
- HCC $34.16
- OGN $1.02
- P/E Ratio
- HCC $78.93
- OGN $3.43
- Revenue Growth
- HCC N/A
- OGN N/A
- 52 Week Low
- HCC $38.00
- OGN $8.01
- 52 Week High
- HCC $75.15
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- HCC 67.93
- OGN 43.79
- Support Level
- HCC $53.04
- OGN $8.32
- Resistance Level
- HCC $60.74
- OGN $10.31
- Average True Range (ATR)
- HCC 2.61
- OGN 0.46
- MACD
- HCC 0.38
- OGN -0.10
- Stochastic Oscillator
- HCC 82.90
- OGN 43.13
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.